Plasma TIM-1 concentration: correlation with cytokines in pulmonary tuberculosis patients and development of a predictive model

Wolazihan Madeniyati, Chunyu Wang, Reyila Tuerhong, Dilixiati Tuerdimaimaiti, Gulisitan Aili, Ajiguli Kulaixi, Remilanmu Nizhamuding, Baihetinisha Tuerdi · 2026

Read Plasma TIM-1 concentration: correlation with cytokines in pulmonary tuberculosis patients and development of a predictive model by Wolazihan Madeniyati, Chunyu Wang, Reyila Tuerhong, Dilixiati Tuerdimaimaiti, Gulisitan Aili, Ajiguli Kulaixi, Remilanmu Nizhamuding, Baihetinisha Tuerdi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13520270.txt.

Description

Wolazihan Madeniyati leads an eight-author biomarker study in 2026 on TIM-1, an immune-regulating protein, in pulmonary tuberculosis. Blood plasma from 60 active tuberculosis patients, 50 people with latent infection, and 50 healthy controls at a Xinjiang hospital was tested for TIM-1 and two signaling molecules, IFN-gamma and IL-17.

Active patients carried significantly more TIM-1 and IL-17, with less IFN-gamma, and TIM-1 levels tracked IL-17 levels closely. Alone, TIM-1 separated patients only moderately well. A combined predictive model reached a discrimination score near 0.79. The authors frame TIM-1 as a candidate aid for early diagnosis and a possible treatment target, while stressing that larger multicenter validation must come first.

Catalog record

CREATORWolazihan Madeniyati, Chunyu Wang, Reyila Tuerhong, Dilixiati Tuerdimaimaiti, Gulisitan Aili, Ajiguli Kulaixi, Remilanmu Nizhamuding, Baihetinisha Tuerdi
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32125
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13520270

Browse the full library · About the Tower of Babel